Literature DB >> 29721943

Neuroinflammation in Retinitis Pigmentosa, Diabetic Retinopathy, and Age-Related Macular Degeneration: A Minireview.

Michael T Massengill1, Chulbul M Ahmed1, Alfred S Lewin1, Cristhian J Ildefonso2.   

Abstract

The eye is an immuno-privileged organ. However, certain diseases such as uveitis are intrinsically linked to inflammation. In several retinal degenerative diseases, there is a unique damage at the onset of the disease, but evidence suggests that chronic and low-grade inflammatory processes play an important role in their progression. Studies have identified similar signaling pathways and changes in resident immune cells within the retina among these diseases. Herein, we will discuss some of these studies and propose how understanding this inflammatory response could aid in the development of therapies.

Entities:  

Keywords:  Age-related macular degeneration; Diabetic retinopathy; Inflammation; Microglia; Müller glia; Retinitis pigmentosa

Mesh:

Substances:

Year:  2018        PMID: 29721943     DOI: 10.1007/978-3-319-75402-4_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

Review 1.  Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Alex Lyakhovich; Luca Tiano; Marco Trifuoggi
Journal:  Cell Mol Life Sci       Date:  2021-10-31       Impact factor: 9.261

Review 2.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

3.  The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Filippo Locri; Valeria Pecci; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli
Journal:  J Cell Mol Med       Date:  2019-06-28       Impact factor: 5.310

4.  RPE-derived exosomes rescue the photoreceptors during retina degeneration: an intraocular approach to deliver exosomes into the subretinal space.

Authors:  Yange Wang; Qian Zhang; Guoqing Yang; Yuanmeng Wei; Miao Li; Enming Du; Haijun Li; Zongming Song; Ye Tao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 5.  Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies.

Authors:  Lorena Olivares-González; Sheyla Velasco; Isabel Campillo; Regina Rodrigo
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

6.  Ferulic acid attenuates microglia-mediated neuroinflammation in retinal degeneration.

Authors:  Xiaowei Sun; Peng Sun; Limei Liu; Pengfei Jiang; Yuanbin Li
Journal:  BMC Ophthalmol       Date:  2021-01-06       Impact factor: 2.209

7.  A novel mutation in the PRPH2 gene in a Chinese pedigree with retinitis pigmentosa and angle-closure glaucoma.

Authors:  Wei-Ning Li; Xiu-Juan Du; Yu-Ting Zhang; Le-Yi Wang; Jing Zhu
Journal:  BMC Ophthalmol       Date:  2021-08-16       Impact factor: 2.209

Review 8.  Importance of Autoimmune Responses in Progression of Retinal Degeneration Initiated by Gene Mutations.

Authors:  Grazyna Adamus
Journal:  Front Med (Lausanne)       Date:  2021-12-02

9.  Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.

Authors:  Xian Zhang; Preston E Girardot; Jana T Sellers; Ying Li; Jiaxing Wang; Micah A Chrenek; Wenfei Wu; Henry Skelton; John M Nickerson; Machelle T Pardue; Jeffrey H Boatright
Journal:  Mol Vis       Date:  2019-08-21       Impact factor: 2.367

10.  Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration.

Authors:  Xian Zhang; Nathaniel F Henneman; Preston E Girardot; Jana T Sellers; Micah A Chrenek; Ying Li; Jiaxing Wang; Charles Brenner; John M Nickerson; Jeffrey H Boatright
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.